FCCC LOGO Faculty Publications
Randomized Controlled Trials in Hereditary Cancer Syndromes
Surgical Oncology Clinics of North America. 2017 Oct;26(4) :729-750
Back to previous list
Abstract
Conducting randomized controlled trials (RCTs) in patients with germline mutations in genes that predispose to adult-onset cancer is hampered by the rarity of these mutations, barriers to their identification, and challenges inherent to randomizing high-risk individuals as part of a clinical trial. Most of the clinically relevant RCTs have been conducted in 3 syndromes in only some of the high-risk genes for which clinical testing is currently available. This article reviews the surgical, screening, and chemoprevention RCTs in each of the syndromes in clinically relevant studies conducted in the past 10 years.
Notes
Export Date: 1 September 2017 Article in Press